SciELO - Scientific Electronic Library Online

 
vol.116 issue6 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

    Related links

    • On index processCited by Google
    • On index processSimilars in Google

    Share


    SAMJ: South African Medical Journal

    On-line version ISSN 2078-5135Print version ISSN 0256-9574

    Abstract

    FERNDALE, L; BHADREE, S  and  CHEN, W C. External validation of a prognostic score for oesophageal cancer (PSOC) for patients treated with palliative intent in a resource-limited setting. SAMJ, S. Afr. med. j. [online]. 2026, vol.116, n.6, pp.17-21. ISSN 2078-5135.  https://doi.org/10.7196/SAMJ.2026.v116i6.4209.

    BACKGROUND. Oesophageal cancer (OC) is common in South Africa (SA), where late presentation limits curative treatment. In resource-constrained settings, staging may not benefit patients with a poor prognosis. The prognostic score for oesophageal cancer (PSOC), based on Eastern Cooperative Oncology Group performance status scale, body mass index and serum albumin, was previously developed to predict short-term survival. OBJECTIVE. To externally validate PSOC in an independent cohort. METHODS. We performed a retrospective validation study using prospectively collected data from two public sector hospitals in KwaZulu-Natal Province, SA. Eligible patients had histologically confirmed OC and complete PSOC data, and were treated with palliative intent. The primary endpoint was survival >3 months. Logistic regression assessed associations between PSOC and survival. Discrimination was quantified using the area under the receiver operating characteristic curve (AUROC), calibration with the Hosmer-Lemeshow test and accuracy with the Brier score. Secondary analyses evaluated overall survival (OS) with Kaplan-Meier and Cox models. RESULTS. We included 465 patients (mean age 61 years; male:female ratio 1:1), 97% with squamous cell carcinoma. Higher PSOC scores predicted improved survival (score 4 v. 0: odds ratio 11.87, 95% confidence interval (CI) 4.87 - 28.91; p<0.001). AUROC was 0.681 (95% CI 0.630 - 0.732) with good calibration (Hosmer-Lemeshow p=0.920). Median OS was 4.8 months, with significant survival differences across score groups (log-rank p<0.001). The Brier score was 0.190, indicating good predictive accuracy. CONCLUSION. PSOC is a simple, validated tool for predicting short-term survival in OC, and may guide decisions on staging v. palliation in high-incidence, resource-limited settings.

    Keywords : oesophageal cancer; palliative care; prognostic score; risk stratification; external validation; survival analysis; AUROC; calibration; Brier score; South Africa.

            · text in English     · English ( pdf )